LP
GRTS

LMR Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

LMR Partners’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-636,300
Closed -$1.64M – 1365
2024
Q1 		$1.64M Buy
+636,300
New +$1.55M 0.02% 590

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LMR Partners's GRTS Position: Q2 2023 in Review

LMR Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 49,051 shares — an estimated $136K sold.

LMR Partners first reported a position in GRTS in Q2 2022 and held it in 3 quarters. The position peaked at $136K in Q1 2023. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

  • LMR Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • LMR Partners sold 49,051 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $136K.
  • LMR Partners first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • LMR Partners's Gritstone bio, Inc. Common Stock position peaked at $136K in Q1 2023.
  • 88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.